Company Profile

Florica Therapeutics Inc
Profile last edited on: 12/14/21      CAGE: 8HFJ4      UEI: U481VWX5JH26

Business Identifier: Extending human lifespa throu development of regenerative medicine therapeutics
Year Founded
2020
First Award
2021
Latest Award
2021
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

953 Indiana Street
Livermore, CA 94107
   (415) 939-3051
   N/A
   floricatherapeutics.com
Location: Single
Congr. District: 12
County: Alameda

Public Profile

With the declared objectives of increasing natural lifespan and detering the diseases of aging, Florica Therapeutics is structured around creating exosome-based therapeutics based on nature and powered by technology. The science underpinning Florica objective as deined by firm's principals: "Exosomes are vesicles containing an array of cargo that are released by cells in order for them to communicate with one another. "They" are released by hypothalamus stem cells are able to increase mouse lifespan by 20%" "Based on nature and powered by technology, Florica Therapeutics creates exosome-based therapeutics to increase lifespan and deter neurological diseases of aging."

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2021 1 NSF $255,678
Project Title: Hypothalamus Stem Cell Exosomes for Treatment of COVID-19 (COVID-19)

Key People / Management

  Christine Ichim -- Founder and CEO

  Terry Hogue

  Sebastian Wong -- Director of Business Developmen

Company News

There are no news available.